bio:cap is the new international INVESTIVAL for innovators and investors in life sciences and AI - where bold ideas meet capital, industry, and policy to become reality.
From 9 - 11 June 2026 at CityCube Berlin, the city becomes a global meeting point - bridging North America and Asia. Across BioTech, TechBio, Diagnostics, and AI, bio:cap is where scientific breakthroughs, industrial innovation, and public decision-making converge.
What to expect?
Hosted by Messe Berlin under the patronage of Charité – Universitätsmedizin Berlin and the Berlin Institute of Health (BIH), and supported by the Hasso Plattner Institute (HPI), bio:cap blends conference and festival into a dynamic, interdisciplinary platform for discovery, investment, and action.
Our mission: connect visionary investors and cutting-edge bio- and tech innovators with global pharma leaders and key policymakers - to fuel breakthroughs, back high-potential ventures, and shape the frameworks that turn Europe’s science into global market success.
Join our community stand
Oslo Cancer Cluster will have a booth in the exhibition area at bio:cap. Oslo Cancer Cluster members, who are currently working in the intersection between cancer innovation and artificial intelligence, have the opportunity to be profiled on a screen at this booth. If you are interested in having your company or organisation profiled, please reach out to Sofia Linden, Communications Adviser (sl@oslocancercluster.no).
Participate in a roundtable
Oslo Cancer Cluster will also co-host a roundtable titled "AI in European Healthcare — Nordic Models & European Pathways" during bio:cap. If you are interested in participating in the roundtable, please reach out to Jutta Heix, Head of International Affairs, Oslo Cancer Cluster (jh@oslocancercluster.no).
TEF Health Event
In connection with bio.cap, there will be a TEF Health Event on Tuesday 9 June 2026, titled “Transforming Healthcare with Trusted AI, Robotics and Data - TEF-Health - Testing and Experimentation Facility for Health and Robotics”. The tickets are EUR 50 and entitle participants to receive a discount to bio:cap tickets.